|
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
|
1R01CA196973-01A1
|
$409,153
|
$409,153
|
GRITSMAN, KIRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
5R01CA182284-04
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Markers of Cognitive Decline During Treatment for Childhood ALL
|
5R21CA187226-02
|
$215,938
|
$215,938
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-03
|
$346,525
|
$173,263
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$15,990
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$15,999
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$40,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$299,691
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
1F30CA210539-01
|
$43,576
|
$21,788
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
|
5R01CA166429-05
|
$384,342
|
$384,342
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-02
|
$312,244
|
$312,244
|
NAPPER, ANDREW
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS
|
4R01CA160747-05
|
$324,738
|
$324,738
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-03
|
$537,748
|
$537,748
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
3P50CA126752-10S1
|
$300,703
|
$111,260
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
4P50CA126752-10
|
$2,344,258
|
$867,375
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
4R01CA164024-04
|
$309,159
|
$309,159
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-02
|
$462,191
|
$462,191
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$11,802
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$17,090
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$11,888
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$49,995
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$13,422
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$325,312
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-03
|
$402,343
|
$402,343
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
1UH2CA213385-01
|
$25,705
|
$25,705
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-03
|
$710,976
|
$710,976
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
1R01CA195519-01A1
|
$272,213
|
$272,213
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
|
5R01CA178387-03
|
$317,475
|
$317,475
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
|
5R00CA184411-04
|
$248,999
|
$248,999
|
LI, LING
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Biologic and Therapeutic Significance of miR-155 in AML
|
1R01CA201184-01
|
$574,050
|
$574,050
|
MARCUCCI, GUIDO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Pharmacological modulation of epigenetic changes in AML
|
5R01CA102031-11
|
$342,107
|
$342,107
|
MARCUCCI, GUIDO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
|
1R01CA201496-01A1
|
$499,409
|
$499,409
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$20,104
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$20,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$5,984
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$56,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$403,200
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting PML for Leukemia Therapy
|
2R01CA142874-06A1
|
$465,791
|
$465,791
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Tumor Suppressive Pathways for Cancer Therapy
|
5R35CA197529-02
|
$1,044,000
|
$1,044,000
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of regulation by RNA in acute myeloid leukemia
|
5R35CA197697-02
|
$1,042,185
|
$1,042,185
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
|
4R01CA161151-04
|
$377,086
|
$188,543
|
YAN, CATHERINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of Jmjd1c in normal and leukemic hematopoiesis
|
5R00CA168996-04
|
$243,927
|
$243,927
|
ZHU, NAN
|
BLOODCENTER OF WISCONSIN, INC.
|
|
Oncogenic Notch Signaling
|
3P01CA119070-10S1
|
$58,609
|
$35,751
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oncogenic Notch Signaling
|
4P01CA119070-10
|
$1,013,309
|
$618,118
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$239,348
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$82,500
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$112,500
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$1,360,203
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-18
|
$2,249,567
|
$2,249,567
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Tribbles-COP1 Complex in Leukemia
|
4K08CA166227-04
|
$178,200
|
$178,200
|
ULJON, SACHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Leukemia for this search: $241,005,895
|